CTKB Cytek Biosciences Inc

For the fiscal year ended 31/12/2022: Cytek Biosciences Inc's revenues increased by 28.20% and amounted to 164.04M. Net income increased by 9,453.85% to 2.48M. Net assets decreased by NaN to 427.82M and EPS decreased from N/A to 0.02.